In this study, combined blocking of TIGIT and PD-1 showed further tumor control, decreased reduction of key factors in glucose metabolism, and significantly inhibit Akt/mTOR signaling pathway compared with either single blocking in tumor-bearing mice. The gene discussed is MTOR; the disease is neoplasm.